Difference between revisions of "Gazdar AF, et al. Nat. Rev. Cancer (2017) cited as Ref 571 in DOI: 10.1038/s41392-020-0110-5 (Q9834)"
Jump to navigation
Jump to search
(Created claim: title (P93): Small-cell lung cancer: what we know what we need to know and the path forward, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 725-737, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 725-737 | ||
| Property / Page(s): 725-737 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Gazdar AF, et al. Nat. Rev. Cancer (2017) cited as Ref 571 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Gazdar AF
0 references
Bunn PA
0 references
Minna JD
0 references
2017
0 references
Nat. Rev. Cancer
0 references
17
0 references
Small-cell lung cancer: what we know what we need to know and the path forward (English)
0 references
725-737
0 references
